High, Low BMI Tied to Higher Medical Expenditures in Children
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, July 3, 2023 -- Medical expenditures, including out-of-pocket (OOP) expenditures, for privately insured children are higher for all body mass index (BMI) categories other than healthy weight, according to a study published online July 3 in JAMA Pediatrics.
Ashutosh Kumar, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estimated medical expenditures among U.S. youth across all BMI categories, as well as by sex and age groups. The analysis included data from the 2018 IQVIA ambulatory electronic medical records (205,876 privately insured individuals aged 2 to 19 years).
The researchers found that compared with children with healthy weight, total and OOP expenditures were higher for all other BMI categories. For total expenditures, differences were highest for those with severe obesity ($909) and underweight ($671) versus healthy weight. For OOP expenditures, differences were also highest for severe obesity ($121) and underweight ($117) versus healthy weight. By age, having underweight was associated with higher total expenditures at ages 2 to 5 years ($679) and 6 to 11 years ($1,166), while having severe obesity was associated with higher total expenditures at ages 2 to 5 years ($1,035), 6 to 11 years ($821), and 12 to 17 years ($1,088).
"The study team found medical expenditures to be higher for all BMI categories when compared with those with healthy weight," the authors write. "These findings may indicate potential economic value of interventions or treatments aimed at reducing BMI-associated health risks."
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.